课题基金 / 基金详情

棘白菌素胁迫下光滑念珠菌持留状态形成与发展机制的多组学研究

批准号:
81971979
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
徐英春
学科分类:
病原生物变异与耐药
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
徐英春

项目摘要

项目成果

徐英春的其他基金

相似基金

相关文献

中文摘要
棘白菌素耐药型光滑念珠菌的出现给临床治疗带来严峻挑战。本课题组在棘白菌素体外杀菌试验中发现,光滑念珠菌在形成稳定耐药前存在持留状态。细菌研究中证实,在高浓度抗菌药物胁迫下持留状态的形成能够提高菌株的存活率和耐药基因突变率,与耐药发展密切相关,但在念珠菌中相关研究匮乏。因此本项目提出重要科学假说,光滑念珠菌在棘白菌素胁迫下形成的持留状态是发展为稳定耐药的重要前提。本项目将1)分析药物作用时间和浓度对持留状态形成的影响;2)从转录组和蛋白质组学角度,联合分析持留菌形成和发展过程中RNA和蛋白水平的动态调控网络,筛选对持留菌形成和发展起关键作用的靶基因,并验证其功能;3)检测我国临床菌株的药物敏感性和持留菌靶基因的表达水平,分析靶基因在不同菌株中的差异。本项目拟通过上述研究,探索棘白菌素胁迫下光滑念珠菌持留状态形成与发展机制,为控制持留状态发生发展、遏制真菌耐药和指导临床合理用药提供新思路。
英文摘要
The emergence of Candida glabrata isolates resistant to echinocandins has proposed great challenges to clinical treatment. In the preliminary in vitro killing assay experiment, we found C. glabrata persister was formed under the stress of echinocandins. It was reported that bacterial persister can increase the number of survival cells and mutation rates under high concentrations of antimicrobial agents, which closely related to resistance development. However, less is known about fungal persister. On this basis, a scientific hypothesis was proposed that the persistence was an important stage before the development of echinocandin resistance. Firstly, our research will analyze the influence from duration of action and concentration of echinocandins on the formation of C. glabrata persistence. Then we will explore the homeostatic molecular mechanism of C. glabrata persistence, based on the multi-omics study including transcriptome and proteome. We will also screen and validate the persister target genes based on expression level of transcription and protein. The antifungal susceptibility and expression level of target genes in clinical invasive C. glabrata isolates will be analyzed. Through overall analysis, this study means to confirm the mechanism of the formation and development of the C. glabrata persister under the stress of echinocandins, which could provide new ideas on controlling C. glabrata persistence formation, reducing clinical resistance and guiding clinical medication.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
Developing Two Rapid Protein Extraction Methods Using Focused-Ultrasonication and Zirconia-Silica Beads for Filamentous Fungi Identification by MALDI-TOF MS.
使用聚焦超声和氧化锆-二氧化硅珠开发两种快速蛋白质提取方法,通过 MALDI-TOF MS 鉴定丝状真菌
DOI: 10.3389/fcimb.2021.687240
发表时间: 2021
期刊: Frontiers in cellular and infection microbiology
影响因子: 5.7
作者: [Ning YT, Yang WH, Zhang W, Xiao M, Wang Y, Zhang JJ, Zhang G, Duan SM, Dong AY, Guo DW, Zou GL, Wen HN, Guo YY, Chen LP, Chai M, He JD, Duan Q, Zhang LX, Zhang L, Xu YC]
通讯作者: Xu YC
DOI: 10.1186/s12866-023-03105-3
发表时间: 2023-11-16
期刊: BMC MICROBIOLOGY
影响因子: 4.2
作者: [Li, Yi, Hou, Xin, Li, Ruoyu, Liao, Kang, Ma, Ling, Wang, Xiaoming, Ji, Ping, Kong, Haishen, Xia, Yun, Ding, Hui, Kang, Wei, Zhang, Ge, Li, Jin, Xiao, Meng, Li, Yingxing, Xu, Yingchun]
通讯作者: Xu, Yingchun
Evaluation of Autof MS 1000 and Vitek MS MALDI-TOF MS System in Identification of Closely-Related Yeasts Causing Invasive Fungal Diseases.
Autof MS 1000 和 Vitek MS MALDI-TOF MS 系统在鉴定引起侵袭性真菌病的密切相关酵母中的评估
DOI: 10.3389/fcimb.2021.628828
发表时间: 2021
期刊: Frontiers in cellular and infection microbiology
影响因子: 5.7
作者: [Yi Q, Xiao M, Fan X, Zhang G, Yang Y, Zhang JJ, Duan SM, Cheng JW, Li Y, Zhou ML, Yu SY, Huang JJ, Chen XF, Hou X, Kong F, Kudinha T, Xu YC]
通讯作者: Xu YC
DOI: 10.3389/fcimb.2021.648988
发表时间: 2021
期刊: Frontiers in cellular and infection microbiology
影响因子: 5.7
作者: [Wu X, Zhang G, Yang WH, Cui JT, Zhang L, Xiao M, Xu YC]
通讯作者: Xu YC
共 6 条
    RTA3基因拷贝数增加逆转近平滑念珠菌对氟康唑耐药性的机制研究
    线粒体抑制希木龙念珠菌活性氧损伤介导其对两性霉素B耐药的机制研究
    近平滑念珠菌唑类药物体内获得/体外诱导耐药机制多组学研究
    国内基金
    海外基金